This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The Ommaya reservoir facilitates repetitive sampling and delivery of drugs into the CSF. The silicone rubber capsule is biologically inert and self-seals after puncture with a small needle; however, more than 200 punctures may predispose to leakage from the capsule. Ommaya complications include infection, hemorrhage, reservoir dysfunction and malpositioning, seizure, focal deficit, and focal leukoencephalopathy.1 The most common organism to infect the reservoir is a coagulase-negative Staphylococcus from skin contamination.2,3⇓ There is no direct relationship between the number of reservoir punctures and infection, but infection usually occurs within weeks of use.2,4⇓ We report three cases of Ommaya infection with Staphylococcus species occurring years after the last puncture of the device (table).
- In this window
- In a new window
Table 1 Patient profiles
Case reports.
Patient 1.
A 20-year-old man had lymphoma without CSF involvement that responded to chemotherapy. He developed headache, and MRI revealed meningeal-based masses. The CSF showed malignant lymphocytes. He was given whole-brain radiotherapy (WBRT), and an Ommaya reservoir was inserted. Intrathecal and systemic chemotherapy with autologous bone marrow transplantation eradicated the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
